150 persons aged from 16 to 65 years found in a diphtheria catamnesis have been observed. Clinical and laboratory as well as ultrasonic signs of kidney lesions in an acute period of a pharynx diphtheria have been studied. These signs corresponded to tubulo-interstitial nephritis. Obtained data testifies that more severe old form of diphtheria in the acute period is more often symptoms of kidneys lesion in a catamnesis period are revealed and they remain throughout long time. 47.5% of patients in a diphtheria catamnesis had clinical-laboratory and echographic signs of kidneys lesion, 81.3% of them clinically presented pain and edematic syndromes, uropoiesis and urine passage disturbances; depression of renal functions (concentration and depurination), an urinary syndrome; sonographic signs of kidneys lesion were observed and manifested at maximum level 1-3 years after an acute period of a pharynx diphtheria. Perimedullary thickness was revealed in 20-45% of patients depending on severity of the disease, it was combined with single and multiple calcifications and a calcification of pyramids papillas. According to ultrasonic data, the nephrocalcinosis has been found 1.2 times oftener after average degree of severity and 2 times oftener after severe degree of severity of pharynx diphtheria in comparison with mild form of the disease. The calcification of papillas of the pyramids, found out in a diphtheria catamnesis, had been developed in a place of necrosis of papillas of pyramids in patients in an acute period of disease.
Download full-text PDF |
Source |
---|
Crit Care Explor
January 2025
Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine/Riley Children's Health, Indianapolis, IN.
Objectives: To investigate the prevalence of pulmonary embolism (PE) in children admitted to critical care diagnosed with COVID-19 infection.
Design: Retrospective database study.
Setting: Data reported to the Virtual Pediatric Systems, 2018-2021.
PLoS Med
January 2025
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Background: Nirmatrelvir with ritonavir (Paxlovid) is indicated for patients with Coronavirus Disease 2019 (COVID-19) who are at risk for progression to severe disease due to the presence of one or more risk factors. Millions of treatment courses have been prescribed in the United States alone. Paxlovid was highly effective at preventing hospitalization and death in clinical trials.
View Article and Find Full Text PDFPLoS One
January 2025
Dept. of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, United States of America.
Opioid dependence is defined by an aversive withdrawal syndrome upon drug cessation that can motivate continued drug-taking, development of opioid use disorder, and precipitate relapse. An understudied but common opioid withdrawal symptom is disrupted sleep, reported as both insomnia and daytime sleepiness. Despite the prevalence and severity of sleep disturbances during opioid withdrawal, there is a gap in our understanding of their interactions.
View Article and Find Full Text PDFCrit Care Explor
January 2025
Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine/Riley Children's Health, Indianapolis, IN.
Objectives: To investigate the prevalence of pulmonary embolism (PE) in children admitted to critical care diagnosed with COVID-19 infection.
Design: Retrospective database study.
Setting: Data reported to the Virtual Pediatric Systems, 2018-2021.
Open Forum Infect Dis
January 2025
COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background: Understanding the risk of hospitalization from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can guide effective public health interventions and severity assessments. This study calculated infection-hospitalization ratios (IHRs) and infection-case ratios (ICRs) to understand the relationship between SARS-CoV-2 infections, cases, and hospitalizations among different age groups during periods of Delta and Omicron variant predominance.
Methods: After calculating antinucleocapsid SARS-CoV-2 antibody seroprevalence using residual commercial laboratory serum specimens, 2 ratios were computed: (1) IHRs using coronavirus disease 2019 hospitalization data and (2) ICRs using Centers for Disease Control and Prevention surveillance data.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!